Molecular Diagnostic Research Laboratory, Center for Sensory Neuroscience, Boys Town National Research Hospital, Omaha, NE 68010, USA.
Int J Mol Sci. 2024 Sep 17;25(18):9993. doi: 10.3390/ijms25189993.
Usher syndrome (USH) is an inherited disorder characterized by sensorineural hearing loss (SNHL), retinitis pigmentosa (RP)-related vision loss, and vestibular dysfunction. USH presents itself as three distinct clinical types, 1, 2, and 3, with no biomarker for early detection. This study aimed to explore whether microRNA (miRNA) expression in USH cell lines is dysregulated compared to the miRNA expression pattern in a cell line derived from a healthy human subject. Lymphocytes from USH patients and healthy individuals were isolated and transformed into stable cell lines using Epstein-Barr virus (EBV). DNA from these cell lines was sequenced using a targeted panel to identify gene variants associated with USH types 1, 2, and 3. Microarray analysis was performed on RNA from both USH and control cell lines using NanoString miRNA microarray technology. Dysregulated miRNAs identified by the microarray were validated using droplet digital PCR technology. DNA sequencing revealed that two USH patients had USH type 1 with gene variants in USH1B () and USH1D (), while the other two patients were classified as USH type 2 () and USH type 3 (), respectively. The NanoString miRNA microarray detected 92 differentially expressed miRNAs in USH cell lines compared to controls. Significantly altered miRNAs exhibited at least a twofold increase or decrease with a value below 0.05. Among these miRNAs, 20 were specific to USH1, 14 to USH2, and 5 to USH3. Three miRNAs that are known as miRNA-183 family which are crucial for inner ear and retina development, have been significantly downregulated as compared to control cells. Subsequently, droplet digital PCR assays confirmed the dysregulation of the 12 most prominent miRNAs in USH cell lines. This study identifies several miRNA signatures in USH cell lines which may have potential utility in Usher syndrome identification.
先天性耳聋综合征(USH)是一种遗传性疾病,其特征是感觉神经性听力损失(SNHL)、与视网膜色素变性(RP)相关的视力丧失和前庭功能障碍。USH 表现为三种不同的临床类型,1、2 和 3,目前尚无早期检测的生物标志物。本研究旨在探索 USH 细胞系中的 microRNA(miRNA)表达是否与源自健康人类供体的细胞系中的 miRNA 表达模式失调。从 USH 患者和健康个体中分离淋巴细胞,并使用 Epstein-Barr 病毒(EBV)将其转化为稳定的细胞系。使用靶向面板对这些细胞系的 DNA 进行测序,以鉴定与 USH 类型 1、2 和 3 相关的基因变体。使用 NanoString miRNA 微阵列技术对 USH 和对照细胞系的 RNA 进行微阵列分析。使用液滴数字 PCR 技术验证微阵列鉴定的失调 miRNA。DNA 测序显示,两名 USH 患者具有 USH1B () 和 USH1D () 基因变异的 USH 类型 1,而另外两名患者分别归类为 USH 类型 2 () 和 USH 类型 3 ()。NanoString miRNA 微阵列检测到 USH 细胞系与对照相比有 92 个差异表达的 miRNA。具有 值低于 0.05 的显著改变的 miRNA 表现出至少两倍的增加或减少。在这些 miRNA 中,20 个是 USH1 特异的,14 个是 USH2 特异的,5 个是 USH3 特异的。三个已知作为内耳和视网膜发育关键的 miRNA-183 家族的 miRNA 与对照细胞相比显著下调。随后,液滴数字 PCR 检测证实了 USH 细胞系中 12 个最显著 miRNA 的失调。本研究确定了 USH 细胞系中的几种 miRNA 特征,这些特征可能在先天性耳聋综合征的识别中具有潜在的应用价值。